Richard Robinet-Duffo

Richard Robinet-Duffo is the Co-Founder and CEO of OGMA, an MIT spin-off deep tech startup developing bio-based nanocatalysts to revolutionize bioprocesses and industrial manufacturing. His work focuses on creating sustainable and cost-efficient alternatives to traditional petrochemical methods, based on technology developed at the MIT Laboratory for Soft Materials. ceraweek+3

Richard has a strong background in healthcare innovation, evidenced by his Master of Science in Healthcare and Data Science from MIT and his research role at Beth Israel Lahey Health. During his time at Lahey, he contributed to optimizing patient intake for their Hospital at Home program, focusing on improving accessibility and exploring automated screening tools. mit

With an academic foundation from HEC Paris and Lycée Sainte-Geneviève, Richard has a diverse professional history spanning private equity at Rothschild & Co, a key role in scaling a digital fertility clinic (Apricity), and experience as a Mathematics Instructor. This demonstrates a blend of analytical skills, entrepreneurial drive, and practical business development experience. ceraweek+1

Richard's academic work includes a 2024 MIT thesis titled "How can brands try to influence social norms?" which delves into the strategies brands use to shape societal perceptions and behaviors, highlighting his interest in the broader societal impact of commercial entities. mit

Beyond his professional pursuits, Richard is a polyglot and a self-identified 'chess addict', indicating a diverse range of personal interests and intellectual curiosity. nitter